Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!

The RNA analysis transcriptomics market is forecasted to achieve notable growth in the coming few years with a forecast CAGR (compound annual growth rate) of more than 13%, as per The Business Research Company’s market report!

Read More On The RNA Analysis Transcriptomics Market Report 2022 – https://www.thebusinessresearchcompany.com/report/RNA-analysis-transcriptomics-global-market-report

The RNA Analysis Transcriptomics Market Size In 2022 And Forecast
The global RNA analysis transcriptomics market is expected to grow from $4.59 billion in 2020 to $5.22 billion in 2021 at a compound annual growth rate (CAGR) of 13.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, affecting many markets across the globe. The RNA analysis/ transcriptomics market is expected to reach $8.62 billion in 2025 at a CAGR of 13.4%.

The RNA analysis/ transcriptomics market consists of sales of RNA analysis products and related services by entities (organizations, sole traders, and partnerships) that provide RNA analysis.

Request for A Free Sample Of The Global RNA Analysis Transcriptomics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5241&type=smp

Increase In Demand For Personalized Medicine Is Driving The Growth Of The RNA Analysis Transcriptomics Market
According to a report on personalized medicines by US FDA, 11 drugs out of 44 new drugs approved in the year 2019 were personalized drugs. Moreover, as per the Personalized Medicine Report 2020 published by the Personalized Medicine Coalition (PMC), the number of personalized medicines in the market more than doubled between 2016 and 2020 in the USA. Therefore, the growing demand for personalized medicines propels the growth of the RNA analysis market.

Competitive Landscape And The Regional Analysis Of The RNA Analysis Transcriptomics Market
Major players in the RNA analysis transcriptomics market are Affymetrix Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., GE Healthcare, Illumina Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd., Sigma-Aldrich Corporation, Thermo Fisher Scientific Inc., Fluidigm Corporation, Promega Corporation, and Biomereiux SA.

The RNA Analysis Transcriptomics Global Market Report 2022  covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the RNA analysis transcriptomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the RNA analysis transcriptomics market.

Technological Advancements And Innovations – A Key Trend In The RNA Analysis Transcriptomics Market
Technologies such as next-generation sequencing (NGS) and RNA interference (RNAi) improved precision and accuracy, which help researchers analyze the transcriptional activity.

RNA Analysis Transcriptomics Market Segmentation By The Business Research Company

1) By Product: Reagents/Consumables, Instruments, Software

2) By Technology, Microarrays, Sequencing, Polymerase Chain Reaction RNA Interference

3) By Application: Clinical Diagnostics, Drug Discovery, Toxicogenomics, Comparative Transcriptomics, RNA Interference

Here Are Some Reports Related To The RNA Analysis Transcriptomics Market –

Medical Image Analysis Software Global Market Report 2022

Single-Cell Analysis Global Market Report 2022

Antisense & RNAi Therapeutics Global Market Report 2022

Get In Touch With Us – Call us at:
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Found this article helpful? Share it on: